02 Jun 2023 Biotalys continues to demonstrate strength of first biocontrol in latest global field trials Member news
26 May 2023 Oxurion reaches enrollment target in KALAHARI Phase 2, Part B trial of novel PKal inhibitor THR-149 in diabetic macular edema Member news
24 May 2023 Galapagos announces start of Phase 2 study with selective TYK2 inhibitor, GLPG3667, in patients with dermatomyositis Member news
04 May 2023 Mithra and the University of Liège secure proof-of-concept for novel manufacturing process of E4 Member news
04 May 2023 flanders.bio and Thermo Fisher Scientific announce strategic partnership to drive innovation and growth Multiple categories
04 May 2023 Vrije Universiteit Brussel (VUB) and InSphero partner to advance drug discovery for Non-Alcoholic Steatohepatitis Member news
03 May 2023 P95 BV and Ampersand Capital Partners join forces to establish first in class vaccine CRO Member news
02 May 2023 Sequana Medical announces FDA clearance of IND application for DSR® 2.0 for treatment of congestive heart failure Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
